Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 961 AL 975

Eight Weeks of Aerobic Interval Training Improves Psychomotor Function in Patients with Parkinson's Disease-Randomized Controlled Trial

Marusiak J, Fisher BE, Jaskólska A, Słotwiński K, Budrewicz S, Koszewicz M, Kisiel-Sajewicz K, Kamiński B, Jaskólski A.

Int J Environ Res Public Health. 2019 Mar 11;16(5):880. doi: 10.3390/ijerph16050880.

Water-soluble CoQ10 as A Promising Anti-aging Agent for Neurological Dysfunction in Brain Mitochondria

Takahashi M, Takahashi K.

Antioxidants (Basel). 2019 Mar 11;8(3):61. doi: 10.3390/antiox8030061.

French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS)

Marques A, Vidal T, Pereira B, Benchetrit E, Socha J, Pineau F, Elbaz A, Artaud F, Mangone G, You H, Cormier F, Galitstky M, Pomies E, Rascol O, Derkinderen P, Weintraub D, Corvol JC, Durif F; DIGPD study group.

Parkinsonism Relat Disord. 2019 Jun;63:117-123. doi: 10.1016/j.parkreldis.2019.02.026. Epub 2019 Mar 4.

Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments

Jakobs M, Fomenko A, Lozano AM, Kiening KL.

EMBO Mol Med. 2019 Apr;11(4):e9575. doi: 10.15252/emmm.201809575.

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease

Eisinger RS, Ramirez-Zamora A, Carbunaru S, Ptak B, Peng-Chen Z, Okun MS, Gunduz A.

Front Neurol. 2019 Feb 26;10:86. doi: 10.3389/fneur.2019.00086. eCollection 2019.

Drug-Induced Parkinsonism Manifesting as Gait Freezing in a Patient With Traumatic Brain Injury: A Case Report

Yoo HS, Kim YW, Kim NY.

Clin Neuropharmacol. 2019 May/Jun;42(3):94-96. doi: 10.1097/WNF.0000000000000333.

Microbiome, Parkinson's Disease and Molecular Mimicry

Miraglia F, Colla E.

Cells. 2019 Mar 7;8(3):222. doi: 10.3390/cells8030222.

Lysosomal dysfunction in proteinopathic neurodegenerative disorders: possible therapeutic roles of cAMP and zinc

Koh JY, Kim HN, Hwang JJ, Kim YH, Park SE.

Mol Brain. 2019 Mar 12;12(1):18. doi: 10.1186/s13041-019-0439-2.

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings

Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B.

Alzheimers Res Ther. 2019 Mar 13;11(1):23. doi: 10.1186/s13195-019-0476-1.

Emerging therapies in Parkinson disease - repurposed drugs and new approaches

Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS.

Nat Rev Neurol. 2019 Apr;15(4):204-223. doi: 10.1038/s41582-019-0155-7.

Re-emergent Tongue Tremor in Neuroleptic-induced Parkinsonism

Prasad S, Holla VV, Pal PK.

Tremor Other Hyperkinet Mov (N Y). 2019 Mar 6;9:632. doi: 10.7916/7ndm-gx63. eCollection 2019.

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH.

J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13.

Neuropsychiatric Symptoms and Cognitive Impairment in Chinese Patients with Parkinson's Disease in Han and Hui Ethnicity

Yao ML, Zhang H, Xu Y, Zhang SM, Gao YZ, Shu M, Zhang JJ.

Curr Med Sci. 2019 Feb;39(1):122-126. doi: 10.1007/s11596-019-2009-3. Epub 2019 Mar 13.

Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson's Disease: A Systematic Review

Ebada MA, Alkanj S, Ebada M, Abdelkarim AH, Diab A, Aziz MAE, Soliman AM, Fayed N, Bahbah EI, Negida A.

CNS Neurol Disord Drug Targets. 2019;18(4):317-325. doi: 10.2174/1871527318666190314101314.

Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies

Guo Y, Xu W, Liu FT, Li JQ, Cao XP, Tan L, Wang J, Yu JT.

Mov Disord. 2019 Jun;34(6):876-883. doi: 10.1002/mds.27665. Epub 2019 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias